Recall Atlas
Drugs & medicalClass III

Zyla Life Sciences US Inc. recalls Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA…

Sub-potent Drug: Lower potency than labeled.

Read the official notice →
Date
2023-11-15
Country
United States
Brand
Zyla Life Sciences US Inc.
Product
Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087.…
Classification
Class III
Units
Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

  1. 2023-11-15
  2. US
    Drugs & medicalClass III

    Grato Holdings, Inc. recalls V-FORCE Homeopathic, 1 FL OZ (30 ml) per glass bottle, Distributed by: BioActive Nutritional, Inc., 1803 N. Wickham Rd., Melbourne, FL 32935

    Incorrect Product Formulation: product contains Active Ingredient Glandula Suprarenalis Suis 8X instead of Glandula Suprarenalis Bovine 8X (as stated on the product label).

    FDA · DrugGrato Holdings, Inc.Distributed to one direct account in Florida with possible further…Official notice →
  3. US
    Drugs & medicalClass II

    Zydus Pharmaceuticals (USA) Inc recalls Oxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd,…

    Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide.Official notice →
  4. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc.,…

    Failed Dissolution Specifications

    FDA · DrugGlenmark Pharmaceuticals Inc., USAUSA nationwideOfficial notice →
  5. US
    Drugs & medicalClass III

    VistaPharm LLC recalls Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA,…

    Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.

    FDA · DrugVistaPharm LLCNationwide and Saudi ArabiaOfficial notice →
  6. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,…

    Failed Dissolution Specifications: Out of specification for dissolution.

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwideOfficial notice →
  7. US
    Drugs & medicalClass II

    MEDLINE INDUSTRIES, LP - Northfield recalls Clinical TREAT Antifungal Powder, Vanilla Scent, 3 OZ (85 g) tube, Active Ingredient: Miconazole Nitrate 2.0% w/w…

    CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation for low assay results on the active ingredient miconazole nitrate.

    FDA · DrugMEDLINE INDUSTRIES, LP - NorthfieldNationwideOfficial notice →
See all drugs & medical recalls →